Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-230
McKhann GM, Cornblath DR, Ho TW, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991;338:593-597
McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342
Gao CY, Ho TW, Wang GL, et al. Acute motor axonal neuropathy. In: Kimura J, Kaji R, eds. Physiology of ALS and relared diseases. Amsterdam: Elsevier, 1997:119-128
Wu HS, Liu TC, Lü ZL, et al. A prospective clinical and electrophysiologic survey of acute flaccid paralysis in Chinese children. Neurology 1997;49:1723-1725
Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine 1969;48:173-215
Honavar M, Tharakan JKJ, Hughes RAC, et al. A clinicopathological study of Guillain-Barré syndrome: nine cases and literature review. Brain 1991;114:1245-1270
Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595
Hafer-Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:627-637
Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39: 17-28
Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996;40:635-644
Van der Meché FGA, Meulstee J, Kleyweg RP. Axonal damage in Guillain-Barré syndrome. Muscle Nerve 1991;14:997-1002
Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms. J Neurol Sci 1993;116:185-192
Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126
Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
Gupta SK, Taly AB, Suresh TG, et al. Acute idiopathic axonal neuropathy (AIAN): a clinical and electrophysiological observation. Acta Neurol Scand 1994;89:220-224
Ho TW, Li CY, Cornblath DR, et al. Patterns of recovery in the Guillain-Barré syndromes. Neurology 1997;48:695-700
Meulstee J, Van der Meché FGA, the Dutch Guillain-Barré Study Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1995;59:482-486
Cornblath DR, Kuncl RW, Mellits ED, et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 1992;15:1111-1115
Brown WF, Feasby TE, Hahn AF. Electrophysiological changes in the acute "axonal" form of Guillain-Barré syndrome. Muscle Nerve 1993;16:200-205
Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol 1988;23:354-359
Rees JH, Soudain SE, Gregson NA, Hughes RAC. A prospective case control study to investigate the relationship between Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379
The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Brain 1996;119: 2053-2061
McLeod JG. Electrophysiological studies in the Guillain-Barré syndrome. Ann Neurol 1981;9(Suppl):S20-S27
Das K, Taly A, Gupta S, et al. Acute inflammatory demyelinating neuropathy: a critical evaluation of diagnostic criteria for demyelination. Electromyogr Clin Neurophysiol 1995;35:451-455
Cornblath DR. Electrophysiology in Guillain-Barré syndrome. Ann Neurol 1990;27(Suppl):S17-S20
Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in Guillain-Barré Syndrome: distinguishing the subtypes. Muscle Nerve 1998 (in press)
Visser LH, Schmitz PIM, Meulstee J, et al. Dutch Guillain-Barré Study Group. Predictors of outcome of Guillain-Barré syndrome after treatment with high-dose intravenous immune globulins or plasma exchange. Ann Neurol 1996;40:511 (Abstract)
Ho TW, Hsieh ST, Nachamkin I, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 1997;48:717-724
Buchwald B, Weishaupt A, Toyka KV, Dudel J. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 1995;201:163-166
Luijckx GJ, Vies J, de Baets M, et al. Guillain-Barré syndrome in mother and newborn child. Lancet 1997;349:27
Buchwald B, Toyka KV, Zielasek J, et al. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann Neurol (In press)
Berciano J, Figols J, Garcia A, et al. Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinico-pathological study. Muscle Nerve 1997;20:846-857
Bohlega S, Stigsby B, Haider A, McLean D. Guillain-Barré syndrome with severe demyelination mimicking axonopathy. Muscle Nerve 1997;20:514-516
Hartung HP, Heininger K, Schäfer B, et al. Immune mechanisms in inflammatory polyneuropathy. Ann NY Acad Sci 1988;540:122-161
Hahn AF, Feasby TE, Wilkie L, Lovgren D. P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration. Acta Neuropathol 1991;82:60-65
Visser LH, Van der Meche FGA, van Doom PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995;118:841-847
Jacobs BC, Meulstee J, van Doom PA, Van der Meché FGA. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré Syndrome. Muscle Nerve 1997;20: 446-452
Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816
Willison HJ. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction. J Neurol Neurosurg Psychiatry 1994;57: 1303-1307
Oomes PG, Jacobs BC, Hazenberg MPH, et al. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol 1995;38: 170-175
Jacobs BC, Hazenberg MP, van Doom PA, et al. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis 1997;175:729-733
Gregson NA, Rees JH, Hughes RAC. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome (GBS). J Neuroimmunol 1997;73: 28-36
Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775
Yuki N, Handa S, Tai T, et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci 1995;130:112-116
Hartung H-P, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part II. Muscle Nerve 1995;18:154-164
Hartung HP, Willison H, Jung S, et al. Autoimmune responses in peripheral nerve. Springer Semin Immunopathol 1996;18: 97-123
